Lynx Biosciences

Private

San Diego, CaliforniaHealthcare & Life Scienceshttps://www.lynx.bio/

Last Round

Seed

Nov 3, 2021

Total Funding Raised

$2.4M

Company Overview

Lynx Biosciences is a biotechnology company that offers a proprietary ex vivo disease biology platform for drug discovery and development in immuno-oncology and immunology.

Sector

Healthcare & Life Sciences

Verticals

Drug Discovery, Biotechnology, Precision Medicine, Medical AI, Healthcare Analytics

Business Model

B2B

Customer Profile

Services & Consulting, Data as a Service

AI Layer

Application

Keywords

ex vivo platformdrug discovery platformAI drug discoverymulti-omicsbiomarker discoveryimmuno-oncologyCROpatient-derived assaysprecision medicinedeep learning analyticsmicrofluidicsdrug target identificationtumor microenvironment modelingfunctional biologyhematological cancers

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Lynx Biosciences Comps

Public and private peers based on sector, stage, and business model.

Lynx Biosciences comps — public and private peers by sector, stage, and business model
Company	Status	Est. Valuation	Rev Multiple
OpenAI	Private	$86.0B	~40x
Cohere	Private	$5.0B	--
Competitor 1	Public	$XX.XB	XXx
Competitor 2	Public	$XX.XB	XXx

View Full Comps Set

Access detailed peer comparisons, multiples, and valuation benchmarks.

Lynx Biosciences Funding Rounds

Historical fundraising activity

Data table
Round	Date	Amount Raised	Valuation	Investors	Sources
Seed	Nov 3, 2021
Seed	Mar 1, 2018

View all Funding Rounds

Key People

Founding team and executive leadership

Chorom Pak

CEO Founder

Founding Team

Lynx Biosciences Investors

Notable investors and investment history

Lynx Biosciences investors
Investor	Rounds
Great Oaks Venture Capital	Seed
WARF Ventures	Seed
Cove Fund	Seed
Checkmate Capital	Seed

View all Investors

Lynx Biosciences Filings

SEC and related filings with document metadata.

Data table
Typed	Date	Amount Offered	Amount Sold	Filling	Pages	Download
Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation
Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation
Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation
Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation

Lynx Biosciences Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about Lynx Biosciences's valuation, stock price, and market status.

Firmographic Details

HeadquartersSan Diego, California

Employee Range12

Year Founded2015

Last FundingNov 3, 2021

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.